ASIA VETS HOLDINGS LTD. (5RE) Fair Value & Analysis
Healthcare · SG · Market cap 11.0M SGD
Fair value as of: Aug 13, 2026
From 9 valuation models · updated 4 days ago
Share price +20.0% over the past month.
A solid business, but screening 18% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.0640 SGD). The favourable scenario is already priced in.
- Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.0210 SGD – 0.1050 SGD · the 0.0780 SGD price screens above the 0.0640 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
ASIA VETS HOLDINGS LTD. (5RE) currently trades at 0.0780 SGD, while our model-based Fair Value estimate is 0.0640 SGD, implying the stock looks roughly 18.0% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at 2.3M SGD. Revenue grew 0.6% year over year. It earns a return on equity of -51.2%. Fundamentals as of Aug 13, 2026
The share trades about 35% below its 52-week high and 271% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -18%, 5RE screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: DCF Models (0.0600 SGD) versus Dividend Discount (0.0100 SGD). Highest evidence: Growth DCF (80).
Notify me when 5RE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 64
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore.
Full company description
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore. The company operates two veterinary clinics, which provides general veterinary services including medical, surgical, and dental care for small animals, such as dogs, cats, rabbits, hamsters, guinea pigs, and chinchillas. It also provides vaccination, health check, dentistry, acupuncture, and traditional Chinese medicines; and natural killer cell and stem cell therapies, in-house blood tests, such as biochemistry and hematology, interventional radiology and endoscopy, surgery and invasive procedures, and pet diet prescription services, as well as diagnostic imaging, which includes ultrasonography, digital radiography, laparoscopy, and endoscopy. Asia Vets Holdings Ltd. was formerly known as Smartflex Holdings Ltd. and changed its name to Asia Vets Holdings Ltd. in July 2018. The company was incorporated in 2010 and is headquartered in Singapore. Asia Vets Holdings Ltd. operates as a subsidiary of Tan Gee Beng Pte. Ltd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
ASIA VETS HOLDINGS LTD. reported revenue of 2.3M SGD in FY2025 versus 3.1M SGD in FY2021, a compound −6.7%/yr. Reported net income was −6.5M SGD in FY2025.
5RE screens 18% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 267 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare ASIA VETS HOLDINGS LTD. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is ASIA VETS HOLDINGS LTD. (5RE) overvalued or undervalued?
What is the fair value of 5RE?
What is the quality score of 5RE?
What is the revenue of ASIA VETS HOLDINGS LTD. (5RE)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track ASIA VETS HOLDINGS LTD. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.